Cyproheptadin plus Risperidon in treatment of children with Autistic Disorder: a double blind, placebo controlled study
Not Applicable
- Conditions
- Autistic Disorder.Childhood autism
- Registration Number
- IRCT201101105280N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
The inclusion criteria were: children aged 3 to 11 with autistic disorder (diagnoses made by the child and adolescent psychiatrist), willingness to participate in the study. Exclusion criteria included: presence of a medical disease and taking any psychiatric drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Autistic Disorder. Timepoint: base line,weeks 4,8. Method of measurement: Childhood Autism Rating Scale(CARS).
- Secondary Outcome Measures
Name Time Method